New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting

Nancy D. Doolittle; Lauren E. Abrey; W. Archie Bleyer; Steven Brem; Thomas P. Davis; Paula Dore-Duffy; Lester R. Drewes; Walter A. Hall; John M. Hoffman; Agnieszka Korfel; Robert Martuza; Leslie L. Muldoon; David Peereboom; Darryl R. Peterson; Samuel D. Rabkin; Quentin Smith; Glen H.J. Stevens; Edward A. Neuwelt

New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting

Nancy D. Doolittle, Lauren E. Abrey, W. Archie Bleyer, Steven Brem, Thomas P. Davis, Paula Dore-Duffy, Lester R. Drewes, Walter A. Hall, John M. Hoffman, Agnieszka Korfel, Robert Martuza, Leslie L. Muldoon, David Peereboom, Darryl R. Peterson, Samuel D. Rabkin, Quentin Smith, Glen H.J. Stevens, Edward A. Neuwelt

Neurology

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

The blood-brain barrier (BBB) presents a major obstacle to the treatment of malignant brain tumors and other central nervous system (CNS) diseases. For this reason, a meeting partially funded by an NIH R13 grant was convened to discuss recent advances and future directions in translational research in neuro-oncology and the BBB. Cell biology and transport across the BBB, delivery of agents to the CNS, neuroimaging, angiogenesis, immunotherapy, and gene therapy, as well as glioma, primary CNS lymphoma, and metastases to the CNS were discussed. Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements.

Original language	English (US)
Pages (from-to)	421-428
Number of pages	8
Journal	Clinical Cancer Research
Volume	11
Issue number	2 I
State	Published - Jan 15 2005

ASJC Scopus subject areas

General Medicine

Cite this

Doolittle, N. D., Abrey, L. E., Bleyer, W. A., Brem, S., Davis, T. P., Dore-Duffy, P., Drewes, L. R., Hall, W. A., Hoffman, J. M., Korfel, A., Martuza, R., Muldoon, L. L., Peereboom, D., Peterson, D. R., Rabkin, S. D., Smith, Q., Stevens, G. H. J., & Neuwelt, E. A. (2005). New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting. Clinical Cancer Research, 11(2 I), 421-428.

New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting. / Doolittle, Nancy D.; Abrey, Lauren E.; Bleyer, W. Archie et al.
In: Clinical Cancer Research, Vol. 11, No. 2 I, 15.01.2005, p. 421-428.

Research output: Contribution to journal › Article › peer-review

Doolittle, ND, Abrey, LE, Bleyer, WA, Brem, S, Davis, TP, Dore-Duffy, P, Drewes, LR, Hall, WA, Hoffman, JM, Korfel, A, Martuza, R, Muldoon, LL, Peereboom, D, Peterson, DR, Rabkin, SD, Smith, Q, Stevens, GHJ & Neuwelt, EA 2005, 'New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting', Clinical Cancer Research, vol. 11, no. 2 I, pp. 421-428.

@article{95977f17c0fb448293f96798020293a3,

title = "New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting",

abstract = "The blood-brain barrier (BBB) presents a major obstacle to the treatment of malignant brain tumors and other central nervous system (CNS) diseases. For this reason, a meeting partially funded by an NIH R13 grant was convened to discuss recent advances and future directions in translational research in neuro-oncology and the BBB. Cell biology and transport across the BBB, delivery of agents to the CNS, neuroimaging, angiogenesis, immunotherapy, and gene therapy, as well as glioma, primary CNS lymphoma, and metastases to the CNS were discussed. Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements.",

author = "Doolittle, {Nancy D.} and Abrey, {Lauren E.} and Bleyer, {W. Archie} and Steven Brem and Davis, {Thomas P.} and Paula Dore-Duffy and Drewes, {Lester R.} and Hall, {Walter A.} and Hoffman, {John M.} and Agnieszka Korfel and Robert Martuza and Muldoon, {Leslie L.} and David Peereboom and Peterson, {Darryl R.} and Rabkin, {Samuel D.} and Quentin Smith and Stevens, {Glen H.J.} and Neuwelt, {Edward A.}",

year = "2005",

month = jan,

day = "15",

language = "English (US)",

volume = "11",

pages = "421--428",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "2 I",

}

TY - JOUR

T1 - New frontiers in translational research in neuro-oncology and the blood-brain barrier

T2 - Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting

AU - Doolittle, Nancy D.

AU - Abrey, Lauren E.

AU - Bleyer, W. Archie

AU - Brem, Steven

AU - Davis, Thomas P.

AU - Dore-Duffy, Paula

AU - Drewes, Lester R.

AU - Hall, Walter A.

AU - Hoffman, John M.

AU - Korfel, Agnieszka

AU - Martuza, Robert

AU - Muldoon, Leslie L.

AU - Peereboom, David

AU - Peterson, Darryl R.

AU - Rabkin, Samuel D.

AU - Smith, Quentin

AU - Stevens, Glen H.J.

AU - Neuwelt, Edward A.

PY - 2005/1/15

Y1 - 2005/1/15

N2 - The blood-brain barrier (BBB) presents a major obstacle to the treatment of malignant brain tumors and other central nervous system (CNS) diseases. For this reason, a meeting partially funded by an NIH R13 grant was convened to discuss recent advances and future directions in translational research in neuro-oncology and the BBB. Cell biology and transport across the BBB, delivery of agents to the CNS, neuroimaging, angiogenesis, immunotherapy, and gene therapy, as well as glioma, primary CNS lymphoma, and metastases to the CNS were discussed. Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements.

AB - The blood-brain barrier (BBB) presents a major obstacle to the treatment of malignant brain tumors and other central nervous system (CNS) diseases. For this reason, a meeting partially funded by an NIH R13 grant was convened to discuss recent advances and future directions in translational research in neuro-oncology and the BBB. Cell biology and transport across the BBB, delivery of agents to the CNS, neuroimaging, angiogenesis, immunotherapy, and gene therapy, as well as glioma, primary CNS lymphoma, and metastases to the CNS were discussed. Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements.

UR - http://www.scopus.com/inward/record.url?scp=19944426039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944426039&partnerID=8YFLogxK

M3 - Article

C2 - 15701824

AN - SCOPUS:19944426039

SN - 1078-0432

VL - 11

SP - 421

EP - 428

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2 I

ER -

New frontiers in translational research in neuro-oncology and the blood-brain barrier: Report of the Tenth Annual Blood-brain Barrier Disruption Consortium Meeting

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this